Delivery Order SPE2DB22D3401-SPE2DB25FT5TM
Award Date 8/19/25
Potential Completion Date 8/20/25
Potential Value $2.5K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Contrave ER 8-90 mg tablets (120 count units) valued at $2,707.41. This firm fixed-price delivery order, with an ultimate completion date of July 28, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was competitively awarded with no set-aside designation. AmerisourceBergen, headquartered...
- The Defense Logistics Agency awarded a delivery order valued at $6,406.51 to AmerisourceBergen Drug Corp for Contrave ER 8-90 mg tablets (120 count) on August 1, 2025, with completion targeted for August 4, 2025. This competitively awarded, firm fixed-price delivery order utilizes no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,988.80 for Contrave ER 8-90 mg tablets (120 count) on August 18, 2025, with an ultimate completion date of August 19, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and specifies performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen's substantial...
- The Defense Logistics Agency awarded a delivery order valued at $22,397.23 to AmerisourceBergen Drug Corp for Contrave ER 8-90 mg tablets (120 count) on July 31, 2025, with an ultimate completion date of August 1, 2025. This competitively awarded, firm fixed-price contract is non-set-aside and performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a $4,065.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Contrave ER 8-90 mg tablets (120-count units) on August 13, 2025, with completion targeted for August 14, 2025. This non-set-aside award represents a standard pharmaceutical supply transaction under the company's broader federal contract portfolio. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Contrave ER 8-90 mg tablets (120-count packages). The contract, valued at $2,533.30, represents a firm fixed-price delivery order with no set-aside designation and an ultimate completion date of August 19, 2025. This award is classified as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order valued at $1,908.07 to AmerisourceBergen Drug Corp for the supply of Contrave ER 8-90 mg tablets (120-count units). This competitively awarded, firm fixed-price delivery order was issued on August 8, 2025, with an ultimate completion date of August 11, 2025. The contract carries no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to compete in open federal procurement processes. The place of...
- The U.S. Defense Logistics Agency (DLA) awarded a $10,587.49 firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of Contrave ER 8-90 mg tablets to support military treatment programs and facilities. The order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen Drug...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order valued at $13,675.32 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading pharmaceutical distribution company. The delivery order is for CONTRAVE ER 8-90 MG TABLET 120S and has a completion date of March 8, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor on this award, which is not designated as a set-aside...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $19,825.61 firm fixed-price delivery order is for the supply of Contrave ER 8-90 mg tablets, a medication used for weight management. The contract has an ultimate completion date of July 19, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...